Fingolimod-related bradycardia is usually asymptomatic, reaches its nadir within 6 hours post-dose and recovers spontaneously. Here we report the case of a 30-year-old MS patient with vagotonia who developed symptomatic bradycardia with 33 beats per minute at nadir 39 hours after a single dose of fingolimod. Bradycardia was responsive to atropine, but returned within 2 hours. Overall, it took a week until the patient recovered. Extended monitoring is advised in patients with symptomatic bradycardia.
CohenJABarkhofFComiG. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med2010; 362: 402–415.
2.
KapposLRadueEWO’ConnorP. A placebo- controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med2010; 362: 387–401.
3.
KoyrakhLRomanMIBrinkmannVWickmanK. The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I. Am J Transplant2005; 5: 529–536.
4.
DiMarcoJPO’ConnorPWCohenJA. First-dose effect of fingolimod: pooled safety data from two phase-3 studies (TRANSFORMS and FREEDOMS). Mult Scler2010; 16(10 Suppl.): S290.
5.
BuddeKSchmouderRLBrunkhorstR. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol2002; 13: 1073–1083.
6.
European Medicines Agency gives new advice to better manage risk of adverse effects on the heart with Gilenya. Press release2012; http://www.ema.europa.eu
7.
LindseyJHaden-PinneriKMemonNBujaL. Sudden unexpected death on fingolimod. Mult Scler J2012; DOI: 10.1177/1352458512438456
8.
EspinosaPSBergerJR.Delayed fingolimod-associated asystole. Mult Scler J2011; 17: 1387–1389.
9.
GuoJMacDonellKLGilesWR. Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells. Eur J Physiol1999; 438: 642–648.
10.
OntanedaDHara-CleaverCRudickRA. Cardiovascular effects and safety of fingolimod in clinical practice. 64th AAN Annual Meeting, 2012; P04. 138.
11.
KovarikJMSladeARiviereGJ. The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects. Br J Clin Pharmacol2008; 66: 199–206.
12.
SchmouderRSerraDWangY. FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects. J Clin Pharmacol2006; 46: 895–904.
